Switzerland Innovation Park Ost AG/Karin Tanner
Innovation Health Hub combines inspiration with medical innovation
17.06.2024
The grand opening of the Health Innovation Hub at Switzerland Innovation Park Ost (SIPO) laid an important foundation stone for future innovations in the field of healthcare. The hub serves as a platform for networking experts from research and industry to jointly drive forward innovative projects in the areas of wearables, health monitoring and disease prevention.
JoPanwatD
Pancreas: nanoparticles for optimized cancer therapy
22.11.2023
Researchers from Göttingen and Karlsruhe have developed a new treatment approach for pancreatic cancer. The innovative method promises to be able to treat the disease in a more targeted way and with fewer side effects in the future. The therapy is now to be optimized for clinical application as quickly as possible.
TU Dresden/IHM
Project for microelectronics resarch in Germany launched
13.09.2023
The BMBF-funded project “Forschungslabore Mikroelektronik Deutschland (ForLab)” brings together 14 German universities active in microelectronics research. Through the ForLab project, they were able to invest in new facilities that will open up new areas of research.
iLexx
Noninvasive technology tests for malaria without a blood sample
10.08.2023
Yale researchers and CytoAstra develop cytophone, a laser-ultrasound platform for noninvasive malaria detection. Funding from Gates Foundation supports prototype development and testing in Burkina Faso. Improved sensitivity offers promising diagnosis and treatment potential, bypassing emerging antigen test challenges.
Eijiro Miyako from JAIST
Cancer photoimmunotherapy: novel liquid metal nanoparticles
09.08.2023
JAIST researchers create liquid metal nanoparticles (PEG-IMIQ-LM) for cancer treatment, merging photothermal therapy and immunotherapy. Disintegration delivers immunomodulants and tracks cancer cells in real-time. Immune checkpoint inhibitor enhances cancer removal. Promising for future cancer theranostics, with clinical trials anticipated in a decade.
Alex Dolce, Florida Atlantic University
U.S. patent for portable tool to diagnose and monitor sickle cell disease
28.06.2023
In the United States, sickle cell disease affects about 100,000 people and about 2 million Americans carry this genetic mutation. The most common and serious problems caused by sickle cell disease are anemia, pain and organ failure – stroke affects about 10 out of 100 children who have this disease. The national median life expectancy for people who have sickle cell disease can reach up to age 50.
ONWARD Medical NV
Kick-off: Marie Skłodowska-Curie Doctoral Network "ReWIRE"
06.04.2023
Through ReWIRE, next-generation scientists will be trained to develop translational breakthrough therapeutic solutions for patients with paralysis caused by traumatic spinal cord injuries.